The EAHP EU Monitor is a regular round up of news relevant to hospital pharmacy in Europe.

You can subscribe to receive the EAHP EU Monitor by email HERE.  

 

One month left to submit your abstract to the 22nd Congress of the EAHP!

Readers of the EAHP EU Monitor are kindly reminded that abstracts for the 22nd Congress of the EAHP (22-24 March 2017, Cannes) must be submitted by a deadline of close of Sunday 16th October 2016.

A range of information about submitting abstracts is provided on the EAHP website, including:

• the abstract review process; 
• guidelines to assist those submitting abstracts for the first time; and 
• tips on avoiding abstract rejection. 

Abstract submissions from all disciplines of hospital pharmacy and related areas are welcomed, including, but not limited to:

• clinical pharmacy; 
• drug distribution; 
• drug information and pharmacotherapy; 
• production and preparation; 
• general Management; 
• pharmacokinetics and pharmacodynamics; and, 
• patient safety and risk management. 

Abstracts must be structured and written in five paragraphs:

• Background, 
• Purpose, 
• Materials and Methods, 
• Results, 
• Conclusions 

Abstracts are limited to not more than 350 words.

The best abstracts/posters, with regards to aspects like originality, scientific quality and practical applicability, will be awarded with 3 prizes amounting to 750 euro, 500 euro and 250 euro.

More information HERE.

 

Experts sought for EMA Advanced Therapy and Pediatric Committees

The European Commission seeks to recruit new civil society representatives to the Committee for Advanced Therapies (CAT) and the Pediatric Committee (PDCO) of the European Medicines Agency (EMA). Interested hospital pharmacists are encouraged to apply before the respective deadlines of 30 September and 31 October.

The Committee for Advanced Therapies (CAT) is the committee at the European Medicines Agency that is responsible for assessing the quality, safety and efficacy of advanced-therapy medicinal products (ATMPs) and following scientific developments in the field. It is a multidisciplinary committee, gathering together some of the best available experts in Europe.

Two members and two alternate members of the CAT are appointed by the European Commission to represent "clinicians", a definition of which may be taken to include hospital pharmacists with practice expertise in the field.

More information about how to apply for the CAT vacancies before the 30 September deadline is available HERE. 

The Paediatric Committee (PDCO) is the committee at the European Medicines Agency that is responsible for assessing the content of paediatric investigation plans and adopting opinions on them. This includes assessing applications for full or partial waivers and assessing applications for deferrals.

Three members and three alternate members of the PDCO are appointed by the European Commission to represent healthcare professionals.

More information about how to apply for the PDCO vacancies before the 31 October deadline is available HERE. 

 

FIP consults pharmacy profession on a Global Vision for the Workforce Development & Global Workforce Development Goals  

The International Pharmaceutical Federation (FIP)'s Education Development Team is inviting pharmacists to provide feedback on a new "Global Vision" for the Pharmacy Workforce, as well supporting "Pharmaceutical Workforce Development Goals". The deadline for responses is Friday 30th September.

It is intended that the final vision and development goals will be agreed at The Global Conference on Pharmacy and Pharmaceutical Sciences Education, taking place on the 7 and 8 November 2016, in Nanjing, China.

Feedback received during the consultation period in advance of the Conference will be used to finesse and refine the final vision and goals.

The Draft Vision Statement is available here. The consultation survey on the Vision Statement is HERE. 

The Draft Workforce Development Goals are available here. The consultation survey on the Workforce Development Goals is available HERE. 

  

EJHP: September edition now published!

September's edition of the European Journal of Hospital Pharmacy includes an editorial on recent regulatory concerns about strong opioids, and original articles on: the impact of pharmacy care upon adherence to cardiovascular medicines; and, antimicrobial consumption in a tertiary children's hospital in Finland.

The edition also contains a systematic review of approaches for calculating the cost of medication errors, as well as a postscript letter on the efficacy of risperidone for the treatment of delirium.

More HERE. 

 

Tony West awarded RPS Lifetime Achievement Prize 

Tony West, the Project Director for Implementation of the European Statements of Hospital Pharmacy, has been recognised by the Royal Pharmaceutical Society (RPS) with an award for Lifetime Achievement.

The award recognises an individual who has made an outstanding contribution to the pharmacy profession throughout their career by promoting pharmacy, innovation, research and development.

Helen Gordon, Chief Executive of the RPS, described West as a "phenomenal leader and role model in hospital pharmacy both in the UK and Europe".

"Among his many achievements has been his development of hospital pharmacy services at Guy's and St Thomas' (London), which have led the way for other hospital pharmacies," she added.

Tony West recently retired from his role as chief pharmacist at Guy's and St Thomas' NHS Foundation Trust, and also served for many years on the Board of Directors of EAHP as Director of Finance. He recently accepted a position as EAHP's Project Director for Implementation of the European Statements of Hospital Pharmacy.

EAHP President Joan Peppard remarked: "I am thrilled that Tony has received this richly deserved recognition of a lifetime's contribution to hospital pharmacy and the patient interest. Tony brings enthusiasm, commitment and a wealth of experience to the practice of pharmacy and its on-going development. We are also delighted that he accepted a new role as EAHP's Project Director for Implementation of the European Statements of Hospital Pharmacy. It's a privilege for EAHP and an advantage for patients in European hospitals to continue to benefit from his knowledge and experience in this way."